Adams Helen C. 4
4 · Immix Biopharma, Inc. · Filed Aug 14, 2023
Insider Transaction Report
Form 4
Adams Helen C.
Director
Transactions
- Award
Stock Options
2023-08-11+20,000→ 20,000 totalExercise: $1.86Exp: 2033-08-11→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Options vest monthly over 12 months from the date of grant.